Research Information Only — Educational content, not medical advice. Repair peptides are research/investigational, not FDA-approved, and carry a cancer caution. Physician review required before use.
PeptideReport.ai
Research › Tissue Repair & Recovery

Research Hub · Tissue Repair & Recovery

Tissue Repair & Recovery Peptides

The most popular corner of peptides for a reason — and the one where matching the compound to the tissue matters most. A torn tendon, a stubborn gut, a sore full-body training load, and a nerve injury are four different problems that route to four different tools. This hub covers the repair peptides, the local-vs-systemic logic behind each, and the one screen that can't be skipped.

Local + Systemic RepairInjury-Type LogicThe Wolverine StackCancer ScreenEvidence-Graded
2Anchor compounds
Local vsSystemic reach
4–8 wkTypical course
0Products sold here
The Peptide Evidence Index
See how all 34 peptides rank by the strength of real human evidence — one honest scorecard.
View the Index →

Why This Hub Exists

Match the compound to the tissue

"Recovery peptides" get stacked blindly all the time, and it half-works — which is exactly the problem. Each compound has a tissue it's best at: BPC-157 for local tendon/ligament/gut, TB-500 for systemic muscle and soft tissue, GHK-Cu for skin and scar, ARA-290 for nerve. Choosing by the tissue you actually injured, rather than by what's popular, is the difference between targeted repair and a scattershot guess.

The core ideaLocal vs systemic is the master distinction. BPC-157 acts at the injury site; TB-500 acts body-wide. Most acute injuries use both — but the reason to use both is coverage, not "more is better."

The Landscape

The compounds, by role

Anchor · Local
BPC-157
Gastric pentadecapeptide · targeted
The local repair anchor — tendon, ligament, and gut. Acts at the injury site, increases VEGF receptors. The default for a specific, localized injury. (Cancer history: avoid.)
 Anchor · Systemic
TB-500
Thymosin β4 fragment · body-wide
The systemic anchor — mobilizes repair cells throughout the body, best for muscle and whole-body soft tissue. Directly raises VEGF production. (Cancer history: avoid.)
 Conditional
GHK-Cu
Copper peptide · skin & scar
Added when skin, collagen, or scar tissue is involved — post-procedure or wound remodeling. Always its own separate syringe.
 Conditional
ARA-290
Innate repair receptor · nerve
For nerve involvement — small-fiber neuropathy and neuropathic pain. A different repair pathway than the angiogenic peptides.
 Conditional
CJC-1295 + Ipamorelin
GH axis · athletic recovery
Added for athletic recovery or high training loads — the GH pathway supports whole-body recovery and body recomposition alongside repair.
 Featured Protocol
Wolverine Stack
BPC-157 + TB-500 combined
The classic acute-injury pairing — local + systemic, VEGF from both sides, same-syringe compatible. Full stack guide →

The Differentiator

The injury type decides the compound

Recovery Selection Logic

What you injured — and where — routes to what gets used.

If acute injury (tendon/ligament/muscle)
→
BPC-157 + TB-500 (Wolverine Stack) — local + systemic.
If skin, scar, or post-procedure
→
Add GHK-Cu — separate syringe, always.
If nerve pain / small-fiber involvement
→
ARA-290 — the nerve-repair pathway.
If high training load / athletic recovery
→
Add CJC-1295 + ipamorelin — GH-pathway support.
Syringe rules: BPC-157 + TB-500 may share a syringe (immediate use) · GHK-Cu is always separate (copper).
The screen that can't be skippedBPC-157 and TB-500 heal partly by growing new blood vessels (angiogenesis) — the same process tumors depend on. Anyone with a cancer history should avoid them, and active cancer is an absolute contraindication. This is the defining safety line in the recovery category.

Mechanism, Plainly

How repair peptides work

01

They grow blood supply to damage

Angiogenesis brings oxygen, nutrients, and repair cells to the injury. It's the shared engine of the anchor compounds — and the source of both their benefit and the cancer caution.

02

Local vs systemic reach

BPC-157 concentrates repair at the injury site; TB-500 mobilizes repair cells across the whole body. Different reach, complementary coverage.

03

They calm the inflammation that stalls healing

Both reduce local and systemic inflammation, moving a chronically inflamed, non-healing injury back into an active repair state.

04

They support repair — they don't replace rehab

These accelerate an active process. Progressive loading or physical therapy during the course is what makes the result durable; resting through it wastes most of the benefit.

Evidence Snapshot

What the research shows

CompoundRoleStatus & evidence
BPC-157Local repairResearch compound (FDA Category 2); extensive preclinical, limited human data. Cancer caution.
TB-500Systemic repairResearch compound; preclinical support for muscle/soft-tissue and cardiac repair. Cancer caution.
GHK-CuSkin/scarCosmetic ingredient + research; controlled data for wound healing and skin, strongest evidence in the category.
ARA-290Nerve repairInvestigational; Phase 2 data in small-fiber neuropathy.

Safety Screen

What gets checked first

Common Questions

Recovery peptide questions answered

BPC-157 or TB-500?
Depends on the tissue. BPC-157 is local — best for a specific tendon, ligament, or gut issue. TB-500 is systemic — best for muscle and body-wide recovery. For an acute injury they're often combined (the Wolverine Stack) because they cover different tissue and drive blood-vessel growth from complementary angles.
Can I use these if I've had cancer?
No. Both anchor compounds heal through angiogenesis, which tumors also rely on. A cancer history means avoid, and active cancer is an absolute contraindication. This is the most important screen in the whole recovery category — no exceptions without an oncologist.
What about nerve pain?
That points to ARA-290, which works through a different (innate repair receptor) pathway aimed at small-fiber nerve repair and neuropathic pain — not the angiogenic mechanism of BPC-157/TB-500.
How long until it works?
Pain often eases in the first 1–2 weeks; functional recovery builds over 4–8 weeks. Crucially, these support an active repair process — doing the rehab (progressive loading, PT) during the course is what makes the result last.

Not Sure Where You Fit?

Take the 60-second quizAnswer a few questions and get honest, clinician-built education matched to your goal — then a personalized report. No hype, no prescription. Which peptide is right for you? →

About the Author

SD
Dr. Scott DelBoccio, DMD
Founding Author · PeptideReport.ai

Dr. DelBoccio is a clinician with thirty years of practice and a focus on peptide pharmacology and regenerative medicine. PeptideReport.ai is the clinician-authored, education-only reference the peptide space lacked — every hub reflects an independent synthesis of the primary literature and the same selection logic that drives the platform's personalized reports. No products are sold on this site.

Full Disclaimer

This hub is for educational and scientific purposes only and does not constitute medical advice, diagnosis, or treatment. The compounds discussed are research/investigational and not FDA-approved; BPC-157 and TB-500 carry a theoretical angiogenesis-related cancer caution and individuals with any cancer history should not use them. Persistent pain or injury warrants evaluation by a licensed physician. PeptideReport.ai does not manufacture, sell, or endorse any preparation. Content addresses adults 21 and older. Evidence and regulatory status continue to evolve.